Phase 4 Study of the Efficacy of Losartan Based Therapy in Hypertensives With and Without Diabetes
Status:
Withdrawn
Trial end date:
2020-12-31
Target enrollment:
Participant gender:
Summary
To study antihypertensive efficacy of 12 weeks of Losartan based therapy Resilo (Losartan)
and Resilo-H (Losartan+ Hydrochlorothiazide) in uncontrolled hypertensive and diabetic
hypertensive patients.